Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities
Crossref DOI link: https://doi.org/10.1007/s00432-015-1975-5
Published Online: 2015-04-22
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Niesen, Judith
Stein, Christoph
Brehm, Hannes
Hehmann-Titt, Grit
Fendel, Rolf
Melmer, Georg
Fischer, Rainer
Barth, Stefan
Text and Data Mining valid from 2015-04-22